China Pharma Holdings CPHI
NYSE CPHI
$0.65 +0.00 (+0.00%)
As of: Sep 30, 2026 · 9:46 AM EDT

China Pharma Holdings (CPHI) Other Operating Expenses (2010 - 2026)

Updated

China Pharma Holdings' Other Operating Expenses was $119,302 in Q2 2026, up 15.5% from $103,324 a year earlier and up 28.7% from the prior quarter.

Analysis

China Pharma Holdings (CPHI) Other Operating Expenses (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, China Pharma Holdings' Other Operating Expenses was $397,675 through Jun 30, 2026, down 20.1% year-over-year; for FY2025, it was $374,768, down 29.9% from FY2024.

  • Other Operating Expenses has now declined for six consecutive years, with a five-year compound annual growth rate of -30.6% (FY2020 to FY2025).
  • In earlier years, Other Operating Expenses was $534,526 in FY2024 (-30.1%), $764,571 in FY2023 (-21.7%), $975,934 in FY2022 (-21.3%) and $1.24 million in FY2021 (-46.8%).
  • The Q2 2026 figure marks the highest quarterly Other Operating Expenses since Q4 2024.
  • Compared with a year earlier, Other Operating Expenses was higher in two of the last eight quarters, with an average decline of 18.6%.
  • The best year-over-year quarter for Other Operating Expenses over five years was Q3 2022 (growth of 30.1%); the worst was Q3 2021 (a decline of 78.8%).
  • Per Business Quant data, CPHI's Other Operating Expenses in the three quarters before Q2 2026 was $92,717 (Q1 2026), $82,313 (Q4 2025) and $103,343 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 China Pharma Holdings 29.58 Mn 28.46 Mn 83,566.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 119,302.00
Mar 31, 2026 92,717.00
Dec 31, 2025 82,313.00
Sep 30, 2025 103,343.00
Jun 30, 2025 103,324.00
Mar 31, 2025 85,788.00
Dec 31, 2024 175,527.00
Sep 30, 2024 132,947.00
Jun 30, 2024 119,931.00
Mar 31, 2024 106,121.00
Dec 31, 2023 267,996.00
Sep 30, 2023 188,312.00
Jun 30, 2023 173,867.00
Mar 31, 2023 134,396.00
Dec 31, 2022 354,261.00
Sep 30, 2022 185,540.00
Jun 30, 2022 262,093.00
Mar 31, 2022 174,040.00
Dec 31, 2021 286,280.00
Sep 30, 2021 142,664.00
API Access

China Pharma Holdings Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=CPHI&period=max&api_key=YOUR_API_KEY